Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia, affecting approximately 335
million patients worldwide. Comprehensive pharmacological treatment of AF includes …

Introduction Per-label dosing of direct oral anticoagulants (DOACs) is important for the
prevention of stroke and systemic embolism among patients with non-valvular atrial …

Background the efficacy and safety of direct oral anticoagulants (DOACs) compared with that
of warfarin in very old patients with non-valvular atrial fibrillation (NVAF) have been reported …

Background: Patients with non-valvular atrial fibrillation with diabetes face increased stroke
and cardiovascular risks. This study compares factor Xa inhibitors and warfarin using data …

Objective: To analyze the clinical effects and economic costs between Warfarin and novel
oral anticoagulants in elderly patients with atrial fibrillation (AF). Methods: This is a …

Background: Cardiovascular diseases (CVDs) are the major cause of mortality and disability
in patients with type 2 diabetes mellitus (T2DM). The increased risk of major cardiovascular …

Abstract Background: Cardiovascular diseases (CVDs) are the major cause of mortality and
disability in patients with type 2 diabetes mellitus (T2DM). The increased risk of major …

Цель. Выявить факторы риска низкой приверженности и разработать шкалу
прогнозирования приверженности. Оценить связь прогностической шкалы с …

Aim. To identify risk factors for low adherence and develop a scale for its prediction. To
evaluate the association of the predictive score with actual low adherence according to the 8 …